Utah Medical Products
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Utah Medical Products generated cash of $22,281,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,165,000 last year. Net change in cash is therefore $17,816,000.
Cash Flow
| 2014 | 15.38M | -1.13M | -8.26M |
|---|---|---|---|
| 2015 | 13.80M | -246K | -8.89M |
| 2016 | 14.52M | -3.30M | -6.34M |
| 2017 | 16.90M | -1.59M | -2.65M |
| 2018 | 16.83M | 534K | -4.77M |
| 2019 | 17.05M | -21.54M | -4.22M |
| 2020 | 20.13M | -860K | -10.73M |
| 2021 | 21.20M | -552K | -10.90M |
| 2022 | 21.14M | -818K | -5.48M |
| 2023 | 22.28M | -639K | -4.16M |
UTMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 75.05M | 60.97M | 51.59M | 42.78M | 51.11M | 39.87M | 26.29M | 23.27M | 19.27M | 14.39M |
Operating activities | ||||||||||
Net income | 16.63M | 16.47M | 14.78M | 10.79M | 14.72M | 18.55M | 8.50M | 12.12M | 11.84M | 11.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 6.36M | 7.08M | 7.28M | 7.20M | 6.88M | 2.95M | 2.77M | 2.83M | 3.14M | 3.35M |
Stock-based compensation expense | 225K | 183K | 166K | 160K | 113K | 64K | 129K | 92K | 87K | 74K |
| Deferred income tax benefit | 225K | 183K | 166K | 160K | 113K | 64K | 129K | 92K | 87K | 74K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 2.27M | -511K | -1.08M | 617K | -738K | -496K | -242K | 295K | 137K | -365K |
Inventories | -670K | -2.35M | -485K | 924K | -1.68M | -244K | -467K | -360K | 422K | -141K |
Accounts payable | -456K | 464K | -23K | -308K | 114K | 52K | 9K | 286K | -265K | 188K |
Cash generated by operating activities | 22.28M | 21.14M | 21.20M | 20.13M | 17.05M | 16.83M | 16.90M | 14.52M | 13.80M | 15.38M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -639K | -818K | -552K | -860K | -21.54M | -402K | -1.59M | -3.30M | -246K | -1.13M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 862K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -639K | -818K | -552K | -860K | -21.54M | 534K | -1.59M | -3.30M | -246K | -1.13M |
Financing activities | ||||||||||
Common Stock Issued | 117K | 174K | 358K | 283K | 283K | 454K | 376K | 343K | 343K | 787K |
Payments for dividends | -4.28M | -3.16M | -11.46M | -4.11M | -4.11M | -4.02M | -2.95M | -3.91M | -3.84M | -3.76M |
Repurchases of common stock | -2.49M | -2.49M | -6.97M | -6.97M | -398K | -1.20M | -2.85M | -2.85M | -683K | -1.05M |
Repayments of term debt | 0 | 0 | -6.61M | -283K | 0 | -454K | 0 | -33K | -4.77M | -4.03M |
Cash used in financing activities | -4.16M | -5.48M | -10.90M | -10.73M | -4.22M | -4.77M | -2.65M | -6.34M | -8.89M | -8.26M |
Net Change In Cash | 17.81M | 14.07M | 9.38M | 8.80M | -8.32M | 11.23M | 13.57M | 3.01M | 4.00M | 4.87M |
Cash at end of period | 92.86M | 75.05M | 60.97M | 51.59M | 42.78M | 51.11M | 39.87M | 26.29M | 23.27M | 19.27M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |